Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

National Survey Reveals Conflicted Mindset Of College Students About ADHD Prescription Stimulant Misuse, Abuse And Diversion

Survey Conducted by Harris Poll on behalf of the Coalition to Prevent ADHD Medication Misuse (CPAMM) to be Used to Inform Educational Efforts


News provided by

Coalition to Prevent ADHD Medication Misuse (CPAMM)

Dec 10, 2014, 03:20 ET

Share this article

Share toX

Share this article

Share toX

WAYNE, Pa., Dec. 10, 2014 /PRNewswire/ -- A recent survey conducted by Harris Poll on behalf of the newly-formed Coalition to Prevent Attention-Deficit/Hyperactivity Disorder (ADHD) Medication Misuse (CPAMM) finds that college students' perceptions and attitudes towards the misuse, abuse and diversion of ADHD prescription stimulants are complex. The findings paint a portrait of students who recognize the risks of misuse, but understand why some students may choose to misuse, given the academic pressures in today's college environment. CPAMM intends to use the findings to inform and develop educational campaigns to help prevent nonmedical use of ADHD prescription stimulants. The survey was conducted online between May 15 and June 11, 2014 among 2,056 US college students (full-time, 91%, part-time, 9%), defined as adults aged 18 to 24 enrolled and seeking a degree at a 4-year college or university and attending at least some in-person classes.1

To view the multimedia assets associated with this release, please click http://www.multivu.com/players/English/7373051-cpamm-survey-reveals-college-students-adhd-prescription-stimulant-abuse-misuse-and-diversion/

Attitudes and perceptions about misuse, abuse and diversion

Based on the survey, college students consider taking ADHD prescription stimulant medications that were not prescribed to them to be unethical (75%), a form of cheating (when used for schoolwork) (59%), extremely/very harmful (73%) and a "big deal" (80%) if someone who doesn't have ADHD uses prescription stimulants, with 65% likening the misuse of ADHD prescription stimulants to do schoolwork to athletes who use performance-enhancing drugs. However, almost one in four students (24%) do believe it is okay for someone who doesn't have ADHD to use prescription stimulants for schoolwork, and 48% believe that students who misuse are just doing what they have to do to keep up with the pressures of college. In addition, 42% of students incorrectly believe that using ADHD prescription stimulants not prescribed to them is no more harmful than an energy drink or a strong cup of coffee.

Further, the majority of students believe the main drivers to start misusing ADHD prescription stimulants are a desire to get good grades (70%) and pressure to succeed (68%). Overall, 64% of students declare that they would "do anything to get an A," and 29% admit they will do whatever it takes to succeed academically even if it requires breaking the rules.

"The survey shines a light on the stress permeating the lives of students on today's college campuses. We want to communicate as a Coalition that there are better, healthier ways to cope," says John MacPhee, Executive Director and CEO of The Jed Foundation, a CPAMM partner.

Another perception of note is that 75% of students believe at least some of their peers have used ADHD prescription stimulants not prescribed to them. Reported rates of actual nonmedical use vary, but a 2013 survey at one large public university indicated that 9.3 percent of college students reported nonmedical use of prescription stimulant medication in the past year.2 

"The misconception that 'everybody is doing it' and that misusing will somehow guarantee better grades is something that CPAMM hopes to challenge by creating peer-to-peer interventions for use by college students," says Ann Quinn-Zobeck, Senior Director of the BACCHUS Initiatives of NASPA, a CPAMM partner.

Groups that are more at risk to misuse

Two groups that stand out are members of Greek organizations (fraternities and sororities) and athletes (members of varsity, junior varsity, intramural and/or club teams). These groups are significantly more likely than their respective counterparts to say they are at least somewhat likely to use ADHD prescription stimulants in a way that is different from a doctor's instructions (Greeks, 40%, non-Greeks, 23%, athletes, 36%, non-athletes, 21%). They are also more likely to believe that using ADHD prescription stimulants without a prescription can help students get better grades even if they don't have ADHD – 52% of Greeks (versus 42% of non-Greeks) and 50% of athletes (versus 41% of non-athletes).

Where do college students believe their peers are getting ADHD prescription stimulants?

The survey reveals that 71% of students believe it is easy to obtain ADHD prescription stimulants without a prescription: 87% of students believe friends who have a prescription are the primary source for those who misuse, and about one in two (48%) also think an avenue to obtain them is pretending to have ADHD and getting a prescription from a health care professional. Of the 8% of students diagnosed with ADHD in the survey, more than a quarter (27%) feel it is acceptable for students with ADHD to share their prescription with a friend. Additionally, 46% of students who are diagnosed with ADHD and have a prescription stimulant feel at least a little pressure to share or sell their medication.3

"We recognize the role that students with ADHD may play, and are committed as a Coalition to instilling a greater sense of responsibility in students appropriately diagnosed with ADHD to not divert their supply and to help them feel empowered to say no when peers approach them for their medication," says Ruth Hughes, Ph.D., Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD), a CPAMM partner.

Dr. Julie Wood, Vice President for Health of the Public and Interprofessional Activities, American Academy of Family Physicians (AAFP), a CPAMM partner, agrees: "For students appropriately diagnosed with ADHD, the medicines may help. However, it is important for students with ADHD to recognize that distributing their medication to others is illegal and could be harmful, and for physicians to recognize their role in helping ensure this recognition."

Students' perception of university policies

Despite recognition of the consequences of misuse, and a belief by two in five students (40%) that misuse is a problem at their school, nearly three in five students (57%) believe that the administration and the professors at their school are unaware of the misuse of ADHD prescription stimulants on campus. Moreover, almost three in five college students (58%) feel that their school does not make it clear that they do not approve of ADHD prescription stimulant medication misuse.

"Many colleges and universities have a policy against ADHD prescription stimulant misuse, abuse and diversion, however as an association that represents more than 14,000 higher education professionals, it is imperative that we increase awareness of the seriousness of the issue for college administrators," says Kevin Kruger, Ph.D., President of NASPA, Student Affairs Administrators in Higher Education, a CPAMM partner.

Next steps for the Coalition to Prevent ADHD Medication Misuse (CPAMM)

"As the first national survey to evaluate the mindset of students surrounding ADHD prescription medication misuse, we find this research to be very insightful and informative," says Gwen Fisher, Senior Director of Corporate Communications, Shire, a CPAMM partner. "As a Coalition, we strive to be a trusted source of information. Understanding the attitudes, motivation, perceptions and misperceptions of college students around the issue is crucial to helping prevent nonmedical use – the primary mission of CPAMM. The data actually points to additional areas for further exploration."

Throughout 2014-2015, CPAMM plans to survey medical professionals to identify primary-care based strategies to help reduce ADHD medication misuse, abuse and diversion. In addition, the Coalition will conduct focus groups among college students and administrators to try to gain a better understanding of how the college environment affects the issue and what kind of programmatic efforts might be most effective. Also, the Coalition will evaluate potential partnerships with other organizations, associations and programs that reach college students. Ultimately, CPAMM intends to develop peer-to-peer interventions for use by college students to help prevent the nonmedical use of ADHD stimulant medications. For more information regarding CPAMM or the "College Students and the Misuse, Abuse and Diversion of ADHD Prescription Stimulant Medications" survey, visit CPAMM.org. Join the conversation online using #CPAMMorg.

About the Coalition to Prevent ADHD Medication Misuse (CPAMM)
The Coalition to Prevent ADHD Medication Misuse (CPAMM) strives to be a trusted source of information on the issue of ADHD prescription medication misuse, abuse and diversion – with a primary focus on college students. CPAMM will also use its knowledge to make a difference and prevent the nonmedical use of these medications. Shire is the sole funder of CPAMM. Other partner organizations do not provide financial contributions to CPAMM. On a case-by-case basis, partners may be compensated to execute research and programming proposals for expenses incurred, as approved by the Coalition. All partners, including Shire, voluntarily contribute to the Coalition through their areas of expertise. For more information, visit www.CPAMM.org.

About the Survey Method
Harris Poll conducted the survey on behalf of the Coalition to Prevent ADHD Medication Misuse (CPAMM). The survey was administered online within the United States between May 15 and June 11, 2014, among 2,056 US college students (full-time, 91%, and part-time, 9%), defined as adults aged 18 to 24 enrolled and seeking a degree at a 4-year college or university and attending at least some in-person classes. Among that group, 164 were diagnosed with ADHD. Data are weighted where necessary by age within gender, race/ethnicity, region, and propensity to be online in order to bring them in line with their actual proportions in the population.

About The Harris Poll
Over the last 5 decades, Harris Polls have become media staples.  With comprehensive experience and precise technique in public opinion polling, along with a proven track record of uncovering consumers' motivations and behaviors, The Harris Poll has gained strong brand recognition around the world. The Harris Poll offers a diverse portfolio of proprietary client solutions to transform relevant insights into actionable foresight for a wide range of industries including health care, technology, public affairs, energy, telecommunications, financial services, insurance, media, retail, restaurant, and consumer packaged goods. Contact us at [email protected] for more information.

1Data are weighted where necessary by age within gender, race/ethnicity, region, and propensity to be online to bring them in line with their actual proportions in the population. For the purpose of the survey, misuse refers to any time the medicine is used in a way that is different from the doctor's instructions and could include people who do not have a prescription for the medication but obtain it and use it, and people who have a prescription but do not use it as directed by their health care provider.

2Source: McCabe, S.E., West, B.T., Teter, C.J. & Boyd, C.J., Trends in Medical Use, Diversion, and Nonmedical Use of Prescription Medications among College Students from 2003 to 2013: Connecting the Dots, Addictive Behaviors (2014), doi: 10.1016/j.addbeh.2014.03.008

3*Caution: small base size (n=96); results should be interpreted as directional in nature.      

Contact: Kelly Walker, [email protected], 717-231-5338

To view the multimedia assets associated with this release, please click http://www.multivu.com/players/English/7373051-cpamm-survey-reveals-college-students-adhd-prescription-stimulant-abuse-misuse-and-diversion/

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/national-survey-reveals-conflicted-mindset-of-college-students-about-adhd-prescription-stimulant-misuse-abuse-and-diversion-300007473.html

SOURCE Coalition to Prevent ADHD Medication Misuse (CPAMM)

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.